Sutro Biopharma Inc (STRO)

Sutro Biopharma Inc (STRO) 재무 분석

*모든 숫자는 백만 단위입니다.

기간 종료일	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
기간	3개월	3개월	3개월	3개월	3개월
Revenues	32.25%9.84	14.52	11.65	9.69	63.75
	10.08%39.73	44.18	49.70	58.15	67.09
Research and Development	13.29%31.70	36.55	36.64	39.85	38.33
Operating Income/Loss	0.78%-29.89	-29.66	-38.05	-48.46	-3.35
Income/Loss From Continuing Operations Before Tax	0.09%-38.53	-38.50	-46.84	-56.86	-11.52
Income Tax Expense/Benefit	106.67%0.00	-0.02	-0.08	-	-0.02
	0.13%-38.53	-38.48	-46.76	-56.86	-11.50
Attributable To Parent	0.13%-38.53	-38.48	-46.76	-56.86	-11.50
Basic Average Shares	26.67%16.57	13.08	-	84.87	84.58
Diluted Average Shares	26.67%16.57	13.08	-	84.87	84.58
Basic Earnings Per Share	20.75%-2.33	-2.94	-	-0.67	-0.14
Diluted Earnings Per Share	20.75%-2.33	-2.94	-	-0.67	-0.14